Literature DB >> 32631601

Sjögren Syndrome and Cancer.

Ann Igoe1, Sali Merjanah2, R Hal Scofield3.   

Abstract

The association between malignancy and rheumatic diseases has been demonstrated in a multitude of studies. Little is understood regarding the pathogenesis of rheumatic and musculoskeletal diseases in association with malignancy. There is strong evidence regarding the association between Sjögren syndrome and lymphoma as well as risk factors for development of lymphoma in these patients. This article discusses the accumulating data on various malignancies described in primary Sjögren syndrome, highlighting non-Hodgkin lymphoma and thyroid, multiple myeloma, and skin cancers. These reported associations may have clinical implications in daily practice and contribute to understanding of both autoimmunity and cancer.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amyloidosis; Autoimmune disease; Lymphoma; Lymphoproliferative disorders; Malignancy; Salivary glands; Sjögren syndrome

Year:  2020        PMID: 32631601     DOI: 10.1016/j.rdc.2020.05.004

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  2 in total

Review 1.  PD-1/PD-L1 Inhibitors in Patients With Preexisting Autoimmune Diseases.

Authors:  Ke Zhang; Xiangyi Kong; Yuan Li; Zhongzhao Wang; Lin Zhang; Lixue Xuan
Journal:  Front Pharmacol       Date:  2022-03-18       Impact factor: 5.810

2.  Proteomics Analysis of Tears and Saliva From Sjogren's Syndrome Patients.

Authors:  Nabangshu Das; Nikhil G Menon; Luiz G N de Almeida; Paige S Woods; Miriam L Heynen; Gregory D Jay; Barbara Caffery; Lyndon Jones; Roman Krawetz; Tannin A Schmidt; Antoine Dufour
Journal:  Front Pharmacol       Date:  2021-12-07       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.